Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
AlgometRx
AddedFeb 16, 2024
UpdatedJun 18, 2026
AlgometRx

AlgometRx

AlgometRx offers innovative pain assessment and analgesic technology through pupil analysis and neuroselective stimulation.

HQ
Washington, D.C., DC, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

AlgometRx was founded with the mission to revolutionize pain assessment and analgesic prescribing through innovative technology. The company's core product, the AlgometRx Nociometer®, utilizes advanced algorithms to analyze pupil dilation in response to neuroselective stimulation, creating a detailed nociceptive profile. This profile helps to accurately characterize pain type and intensity, as well as assess the pharmacodynamic impact of analgesics. AlgometRx aims to bring objectivity and precision to pain management across various populations.

Notable figures associated with AlgometRx include experts in pain management and technology innovation, though specific names are not provided. The company has achieved significant milestones by developing a transformative platform that shifts the paradigm in pain assessment. Their technology has the potential to greatly impact clinical practices, improving patient outcomes through more accurate and personalized pain management strategies.

AlgometRx - Similar Companies

PainQx logo

PainQx

painqx.com

Doloromics logo

Doloromics

doloromics.com

XpressiveTech logo

XpressiveTech

xpressivetech.com

Concentric Analgesics logo

Concentric Analgesics

Vapogenix logo

Vapogenix

vapogenix.com

Amalgent Therapeutics logo

Amalgent Therapeutics

amalgent.com

Allay Therapeutics logo

Allay Therapeutics

allaytx.com

NeuroMetrix logo

NeuroMetrix

neurometrix.com

PainNavigator logo

PainNavigator

navigatemypain.com

Alleviate logo

Alleviate

Neurocarrus logo

Neurocarrus

neurocarrus.com

Prohuman Technologies logo

Prohuman Technologies

Thermaquil logo

Thermaquil

thermaquil.com

NeuraLace Medical logo

NeuraLace Medical

JointMetrix Medical logo

JointMetrix Medical

AlgometRx - Quick Facts

Who are AlgometRx's competitors?

Companies similar to AlgometRx include PainQx, Doloromics, XpressiveTech and Concentric Analgesics.

When was AlgometRx founded?

AlgometRx was founded in 2015.

Where is AlgometRx's headquarters located?

AlgometRx's headquarters is located in Washington, D.C., DC, US.

When was AlgometRx's last funding round?

AlgometRx's most recent funding round was for $50k (USD) in November 2017.

How much has AlgometRx raised to-date?

As of Nov 17, 2017, AlgometRx has raised a total of $1.1M (USD).

How many employees does AlgometRx have?

AlgometRx has 5 employees as of Feb 5, 2024.

AlgometRx - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • AI
  • Analytics
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Analgesics
  • Pain Assessment
Tags
  • Healthcare
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 22 more industry codes
NAICS
  • 513200Software Publishers
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 330000Manufacturing
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 7300Business Services
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research